Markets

Indoco Remedies shares jump thirteen percent as technical momentum and profitability return

Originally reported by LiveMint Markets as: Indoco Remedies share price jumps 13%; pharma stock up over 16% in 2 weeks: Can the rally extend? What experts say

18 Nov 2026, 12:13 pm IST · Xecute.finance News DeskArchive edition

The crisp read

Indoco Remedies shares climbed 13.21 percent over the past week, driven by stronger technical indicators and a return to quarterly profits. Market analysts point to resistance between 256 and 260 rupees and support near 230 to 235 rupees, with a successful breakout potentially driving the stock toward 280 to 288 rupees.

Xecute Impact Breakdown

For CAs

  • Not specified in the update
  • Not specified in the update

For businesses

  • Indoco Remedies shares jumped 13.21 percent over a week, supported by improving technical momentum and a return to quarterly profitability.
  • Market analysts identified resistance levels between 256 and 260 rupees and a support zone ranging from 230 to 235 rupees, with a potential target range of 280 to 288 rupees if a breakout occurs.

Deep dive – the full story

Indoco Remedies shares jumped 13.21 percent over the course of a week, supported by improving technical momentum alongside a return to quarterly profitability. Market analysts identified crucial resistance levels between 256 and 260 rupees, alongside a support zone ranging from 230 to 235 rupees. Experts note that a confirmed breakout past these established barriers could pave the way for the equity to advance toward the 280 to 288 rupees target range. Stock price rallies driven by technical momentum reflect shifts in market sentiment and buying pressure relative to historical trading bands.

Resistance zones represent price levels where selling interest historically overcomes buying demand, while support areas indicate floors where buyers typically step in to accumulate shares. Understanding these technical thresholds allows investors to differentiate between short-term speculative spikes and sustained breakouts by comparing current market price action against prior trading ranges. Investors and market participants should monitor price movements around the 230 to 235 rupees support level and the 256 to 260 rupees resistance band before adjusting portfolio allocations in pharmaceutical stocks.

Review technical indicators alongside underlying corporate fundamentals rather than relying solely on short-term price momentum. Bottom line: assess technical resistance and support boundaries carefully before committing capital to rallying pharmaceutical equities.

Source: livemint.com

This is news/educational content, not investment advice. Xecute.finance is not SEBI-registered. Consult a qualified professional before acting.

More from the Xecute news desk

Reading the archive edition.

This story has retired from the live feed - the full text stays here permanently. The live app adds the newest desk, Ask Xecute, deadline trackers and the daily quiz.

Open this story in the Xecute app →